Evaluating the Effectiveness of a Colonoscopy Surveillance Recommendations Algorithm in Clinical Practice
NYU Langone Health · NCT07658716
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- March 24, 2026
- Record last updated
- June 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The primary objective is to determine if the use of the colonoscopy surveillance recommendations algorithm increases the accuracy of surveillance timing recommendations compared to traditional methods. The secondary objective is to assess the time required to make surveillance recommendations with and without the algorithm, determine the efficiency gains (the average time saved per recommendation), and evaluate the opportunity cost (the financial value of the time saved).
Conditions: Colonoscopy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Gastroenterologists and primary care physicians, including residents and fellows, currently practicing at NYU Langone Health, and Bellevue.
- Willing and able to provide consent
Exclusion Criteria
- Physicians not practicing in relevant fields or those with conflicts of interest.
Recruiting US locations
NYU Langone Health
New York, NY 10016
Study contacts (from the official record)
- Renee Williams, MD · 212-562-6647 · Renee.williams@nyulangone.org
Similar studies in New York
All healthy volunteers studies in New York →- RecruitingHealthy volunteers
Using Middle School Science Teachers to Address Cancer Health Disparities
Weill Medical College of Cornell University
- Location
- New York, NY + 1 other US site
- Eligibility basics
- Ages 10+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Staten Island, NY + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- East Syracuse, NY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1